Logo de Macopharma
Contact us

macopharma

How Macopharma is responding to the global pandemic, Covid-19

The world has gone through a very challenging and dramatic period the past couple of months. Macopharma would like to join the collective voice in thanking all the Healthcare workers and every person involved in helping people go through these difficult times. We have done our utmost to play our role and delivering the lifesaving products our customers need, including Transfusion and Biotherapy products as well as the much-needed FFP2 protective masks. This is thanks to the resilience and commitment of our employees worldwide.
Macopharma will continue to strive to serve its customers to the best of its abilities.
View more « Macopharma was pleased to announce last October the first entry product in the viscosupplementation market with HYAJOINT Plus. This medical device is indicated for treatment of pain in osteoarthritis of the knee joint. » View more transfusion macopharma

''We believe in making
the best out of every dr  p
of blood that flows from
a donor to a patient.''

View more
transfusion macopharma

Transfusion

Transfusion is at the core of who Macopharma is,
and the foundation of our expertise and long history.

For many years, we have been at the forefront of innovation and striving for improvement to patient care via more efficient processes and products for the full chain of Transfusion from donor to patient. Every step of the way, we have enabled our customers to collect, process, store and distribute blood components that meet the highest safety and quality standards for patient transfusion.

This has given us the opportunity to develop a recognized, deep knowledge of all aspects of transfusion practices. With our open collaboration mindset and approach, we have been able to help and support blood banks around the world not just with our recognized products and technologies, but also through our service and input into process optimization and streamlining.
Whatever the need in blood collection, blood processing, and blood safety, you can count on Macopharma.

View more

Biotherapy

Biotherapy is Macopharma’s incubator of innovation.

Using our combined industrial and technology-based or scientific expertise, we develop new solutions in other therapeutic areas with unmet patient and healthcare practitioner needs

A 360° offering in bio-sourced therapie

Our core knowledge in Transfusion devices (bags, conservation and illumination) serves in the constant development of a wide range of therapeutic solutions for cellular and tissue therapies that answer different clinical needs and specific medical contexts.

Our extensive expertise in blood processes and derivatives has also motivated us to seek other significant ways we can apply this knowledge to improve the quality of life for patients suffering life-altering disease.  By entering the field of sports medicine and articular pathologies, we continue to expand our horizons to improve donor/patient comfort and health.

View more
Patient testimonial

 

Receiving so many transfusions, it’s a gift of life!

In early 2000 (in October 1997), I was diagnosed with widespread cancer (T-cell lymphoma) that had reached my kidneys, my liver, my bone marrow and my spleen. I was severely affected psychologically and physically.
I received as much as 300 units within 100 days a lot of blood transfusions to survive. In life, you must not remain alone… and it was thanks to a series of human actions that saved me. I am alive today because of Macopharma. Every person in the company, at every stage of the process, is devoted to ensuring that other people in the world can live.

Thank you.

Patrick Bérard,
Executive Manager Foundation Héma-Quebec

Fondation Héma-Québec
patrick benard macopharma
Macopharma in numbers
1
employees
worldwide
1
production sites (France, Poland and Tunisia)
1
commercial
subsidiaries
1
countries
1
M euros
turnover in 2019
Our Timeline

Foundation of
Macopharma

1977

First affiliate
in Germany

1995

New ISO 9001 production site
in Poland

2002

First sales in USA for
Leucolab LCG2 (dockable filter)

2003

New production site
in Tunisia

2012

40 years supporting life

2017

Joint Venture in China
Launch of products in Sports Medicine and Orthopaedics

2019

Re-launch of Protective Masks activity

2020

1977
2002
2012
2017
2019
Our News
View more
Macopharma Worldwide

Distributors

Subsidiaries

Branch offices

Production Sites

Menu